Precision BioSciences
DTIL
DTIL
86 hedge funds and large institutions have $36.5M invested in Precision BioSciences in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
39% less capital invested
Capital invested by funds: $60M → $36.5M (-$23.6M)
67% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 21
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
86
Holding in Top 10
–
Calls
$8K
Puts
$9K
Top Buyers
| 1 | +$3.24M | |
| 2 | +$691K | |
| 3 | +$653K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$593K |
| 5 |
JPMorgan Chase & Co
New York
|
+$390K |
Top Sellers
| 1 | -$5.99M | |
| 2 | -$3.16M | |
| 3 | -$818K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$355K |
| 5 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
-$226K |